MoneyWorks4Me

Clarification sought from Neuland Laboratories

01 Mar 2017 Evaluate

The Exchange has sought clarification from Neuland Laboratories on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017, ‘US FDA grants priority review for SD-809’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..